Instituto de Investigación Sanitaria Biobizkaia-ko ikertzaileekin lankidetzan egindako argitalpenak (44)

2024

  1. Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results

    Vaccines, Vol. 12, Núm. 8

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. GATEKEEPER's Strategy for the Multinational Large-Scale Piloting of an eHealth Platform: Tutorial on How to Identify Relevant Settings and Use Cases

    Journal of medical Internet research, Vol. 25, pp. e42187

  4. Prediction of significant coronary artery disease in acute chest pain without infarction in emergency department: MAPAC Cardio-PreTest model

    European Journal of Emergency Medicine, Vol. 30, Núm. 1, pp. 40-46

  5. Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

    The Lancet Regional Health - Europe, Vol. 28

  6. Violence in first-episode psychosis: Evidence from an early intervention in psychosis programme

    BJPsych Open, Vol. 9, Núm. 5

2022

  1. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  2. Effectiveness of the vagino-rectal exudate self-sampling for prenatal screening of Streptococcus agalactiae infection. GALL study

    Atencion Primaria, Vol. 54, Núm. 6

  3. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

    The Lancet Infectious Diseases, Vol. 22, Núm. 3, pp. 329-340

  4. Erythrocyte Membrane Nanomechanical Rigidity Is Decreased in Obese Patients

    International Journal of Molecular Sciences, Vol. 23, Núm. 3

  5. Flexible multiplex PCR to detect SARS-CoV-2, coronavirus OC43 and influenza A virus in nasopharyngeal swab samples

    Journal of Applied Microbiology, Vol. 133, Núm. 6, pp. 3534-3545

  6. Gender differences in drug titration among heart failure patients with reduced ejection fraction in the ETIFIC trial

    Revista Espanola de Cardiologia, Vol. 75, Núm. 8, pp. 636-648

  7. Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study

    eClinicalMedicine, Vol. 51

  8. Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

    eClinicalMedicine, Vol. 50

  9. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Effectiveness of a structured group intervention based on pain neuroscience education for patients with fibromyalgia in primary care: A multicentre randomized open-label controlled trial

    European Journal of Pain (United Kingdom), Vol. 25, Núm. 5, pp. 1137-1149

  2. Exploring attitudes towards use of technology to support stroke survivors living at home: A quantitative and qualitative content analysis study in Spain

    JOURNAL OF REHABILITATION AND ASSISTIVE TECHNOLOGIES ENGINEERING, Vol. 8

  3. Facilitators and barriers to participation in population-based colorectal cancer screening programme from the perspective of healthcare professionals: Qualitative research study

    European Journal of Cancer Care, Vol. 30, Núm. 6

  4. Implicación de los profesionales de atención primaria en el programa de detección precoz de cáncer colorrectal del País Vasco

    Revista espanola de salud publica, Vol. 95